1-8 of 8
Yasuhide Yamada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer

Raju Kandimalla, Feng Gao, Takatoshi Matsuyama, Toshiaki Ishikawa, Hiroyuki Uetake, Naoki Takahashi, Yasuhide Yamada, Carlos Becerra, Scott Kopetz, Xin Wang, Ajay Goel
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (16): 3867–3877.
https://doi.org/10.1158/1078-0432.CCR-17-3236
Published: 14 August 2018
View article titled, Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer
Open the PDF for Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma

Jean-Pierre Delord, Caroline Robert, Marta Nyakas, Grant A. McArthur, Ragini Kudchakar, Amit Mahipal, Yasuhide Yamada, Ryan Sullivan, Ana Arance, Richard F. Kefford, Matteo S. Carlino, Manuel Hidalgo, Carlos Gomez-Roca, Daniela Michel, Abdelkader Seroutou, Vassilios Aslanis, Giordano Caponigro, Darrin D. Stuart, Laure Moutouh-de Parseval, Tim Demuth, Reinhard Dummer
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5339–5348.
https://doi.org/10.1158/1078-0432.CCR-16-2923
Published: 15 September 2017
View article titled, Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic <em>BRAF</em>-Mutant Melanoma
Open the PDF for Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic <em>BRAF</em>-Mutant Melanoma in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors

Kazuhiko Yamada, Noboru Yamamoto, Yasuhide Yamada, Hiroshi Nokihara, Yutaka Fujiwara, Taizo Hirata, Fumiaki Koizumi, Kazuto Nishio, Noriyuki Koyama, Tomohide Tamura
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (8): 2528–2537.
https://doi.org/10.1158/1078-0432.CCR-10-2638
Published: 14 April 2011
View article titled, Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors

Tetsuya Hamaguchi, Toshihiko Doi, Takako Eguchi-Nakajima, Ken Kato, Yasuhide Yamada, Yasuhiro Shimada, Nozomu Fuse, Atsushi Ohtsu, Shin-ichi Matsumoto, Masaya Takanashi, Yasuhiro Matsumura
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (20): 5058–5066.
https://doi.org/10.1158/1078-0432.CCR-10-0387
Published: 15 October 2010
View article titled, Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors
Open the PDF for Phase I Study of NK012, a Novel SN-38–Incorporating Micellar Nanoparticle, in Adult Patients with Solid Tumors in another window
Journal Articles

Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer

Junichi Matsubara, Yasuhide Yamada, Yoshinori Hirashima, Daisuke Takahari, Natsuko T. Okita, Ken Kato, Tetsuya Hamaguchi, Kuniaki Shirao, Yasuhiro Shimada, Tadakazu Shimoda
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (10): 3022–3029.
https://doi.org/10.1158/1078-0432.CCR-07-1898
Published: 15 May 2008
View article titled, Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer
Open the PDF for Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer in another window
Journal Articles

AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

Masayuki Takeda, Tokuzo Arao, Hideyuki Yokote, Teruo Komatsu, Kazuyoshi Yanagihara, Hiroki Sasaki, Yasuhide Yamada, Tomohide Tamura, Kazuya Fukuoka, Hiroshi Kimura, Nagahiro Saijo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3051–3057.
https://doi.org/10.1158/1078-0432.CCR-06-2743
Published: 15 May 2007
View article titled, AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor
Open the PDF for AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor in another window
Journal Articles

CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity

Anthe S. Zandvliet, Alwin D.R. Huitema, William Copalu, Yasuhide Yamada, Tomohide Tamura, Jos H. Beijnen, Jan H.M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 2970–2976.
https://doi.org/10.1158/1078-0432.CCR-06-2978
Published: 15 May 2007
View article titled, CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity
Open the PDF for CYP2C9 and CYP2C19 Polymorphic Forms Are Related to Increased Indisulam Exposure and Higher Risk of Severe Hematologic Toxicity in another window
Journal Articles

Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug

Koichi Hirata, Noboru Horikoshi, Keisuke Aiba, Minoru Okazaki, Ryuichi Denno, Kazuaki Sasaki, Yasuyuki Nakano, Hikaru Ishizuka, Yasuhide Yamada, Shinji Uno, Tetsuo Taguchi, Tetsuhiko Shirasaka
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 2000–2005.
Published: 01 August 1999
View article titled, Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug
Open the PDF for Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug in another window